CMS Exploring Effect On Clinical Care Of NCDs For TMR, PET, Cryosurgery
This article was originally published in The Gray Sheet
Executive Summary
The effect of previous national coverage decisions (NCDs) on clinical care of patients receiving certain transmyocardial revascularization (TMR), oncology positron emission tomography (PET) and prostate cancer cryosurgery treatments will be explored by CMS, according to Office of Clinical Standards and Quality Acting Deputy Director Sean Tunis